Latest News and Press Releases
Want to stay updated on the latest news?
-
Nordic Iron Ore AB är stolta att kunna meddela att Inlandsinnovation har beslutat att medverka med 20 MSEK i den kommande riktade emissionen som Kopparberg Mineral AB:s intressebolag genomför....
-
Elektrėnai, Lithuania, 2014-06-25 08:39 CEST (GLOBE NEWSWIRE) -- The extraordinary general meeting of shareholders of public company “Lietuvos energijos gamyba”, AB (company code: 302648707, legal...
-
NASDAQ OMX Stockholm decides to officially list 1 bond loan issued by Swedbank AB with effect from 2014-06-26. The instrument will be listed on STO Structured Products. Please find instrument...
-
Panevėžio statybos trestas AB has received the notification of the company manager on the transactions in securities issued by the company (see attachment). Issuer’s...
-
NASDAQ OMX Stockholm decides to officially list 1 bond loan issued by Swedbank AB with effect from 2014-06-26. The instrument will be listed on STO Structured Products. Please find instrument...
-
OUTOTEC (FILTERS) OY PAIKALLISTIEDOTE 25.6.2014 KLO 9.30Outotec sai päätökseen YT-neuvottelut Lappeenrannan tuotantoyksikön lomautuksistaOutotec sai päätökseen Lappeenrannan tuotantoyksikön...
-
Bure Equity AB har träffat avtal med Livränteanstalten Hereditas (”Hereditas”) om att förvärva 20,11 % i Fondbolaget Fondita Ab (”Fondita”), en ledande oberoende förvaltare av aktiefonder. Fondita,...
-
NEW YORK, June 25, 2014 (GLOBE NEWSWIRE) -- Lyfebulb, an organization dedicated to helping people achieve their optimal lifestyle by addressing general and chronic health concerns, and Immune...
-
Uppsala, Sweden – June 25, 2014 – Orexo announces top-line data from a Phase 3 clinical trial demonstrating that Zubsolv® (buprenorphine/naloxone CIII sublingual tablet) is as effective as Suboxone®...
-
Uppsala – 25 juni, 2014 – Orexo meddelar att data från en klinisk Fas III-studie visar att Zubsolv® (buprenorfin/naloxon sublingual tablett) är lika effektiv som Suboxone® film för behandling av...